Funding for this research was provided by:
Narodowe Centrum Badań i Rozwoju (STRATEGMED1/233209/12/NCBR/2015)
Received: 18 June 2021
Accepted: 21 February 2022
First Online: 7 March 2022
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflict of interest. M.M. received an unrestricted grant from BioIncept. E.R.B. is the founder of BioIncept and sPIF is BioIncept proprietary.